Abstract
[This corrects the article DOI: 10.18632/oncotarget.13466.].
Highlights
Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
This article has been corrected: The correct Funding information is given below: FUNDING
Read more 
Summary
Introduction
Oncotarget, 2018, Vol 9, (No 27), pp: 19459-19459
Results
Conclusion
Sign-in/Register to view highlights & summary Full Text Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
